The market is witnessing steady growth, driven by factors such as the rising incidence of traumatic injuries, the increasing geriatric population, and advancements in trauma fixation devices. Trauma fixation devices are used to stabilize and support fractured bones, facilitating the healing process. The market is characterized by a wide range of products, including internal fixation devices (such as plates, screws, and nails) and external fixation devices (such as fixators and splints). The market is also benefiting from technological advancements, such as the development of biodegradable implants and minimally invasive surgery techniques, which offer reduced recovery times and improved patient outcomes. In addition, the growing adoption of orthopedic implants in emerging economies and increasing investments in healthcare infrastructure are driving market growth. The market is expected to continue its growth trajectory, fueled by ongoing research and development activities aimed at introducing innovative products and technologies.
The Global Trauma Fixation Market size is projected to reach USD 20,528.35 million by 2029, with a CAGR of 10.3% during the forecast period of 2022 to 2029.
Below are the Top Five Trauma Fixation Companies with a Significant Market Share:
|
Rank
|
Company
|
Overview
|
Product Portfolio
|
Sales Geographical Coverage
|
Developments
|
|
1.
|
Johnson & Johnson Services, Inc.
|
Johnson & Johnson Services, Inc. is a subsidiary of Johnson & Johnson, a multinational corporation that focuses on healthcare products, including medical devices, pharmaceuticals, and consumer goods. In the trauma fixation market, Johnson & Johnson offers a range of products under its DePuy Synthes division, which is a leader in orthopedic and trauma solutions.
DePuy Synthes provides a comprehensive portfolio of trauma fixation devices, including plates, screws, nails, and external fixators. These devices are designed to stabilize and support fractures in various parts of the body, helping patients to recover and regain mobility. The company is known for its innovative products, such as the LCP (Locking Compression Plate) system, which provides strong and stable fixation for complex fractures.
|
|
North America, Middle East and Africa, Europe, South America, Asia-Pacific
|
In March 2024, Johnson & Johnson MedTech announced a partnership with NVIDIA to enhance and expand the use of artificial intelligence (AI) in surgical procedures. This collaboration aims to improve access to real-time analysis and make AI algorithms for surgical decision-making, education, and collaboration more widely available in connected operating rooms (ORs).
The partnership seeks to speed up the integration of AI into Johnson & Johnson MedTech's range of surgical technologies using NVIDIA's healthcare AI platform. This will enable quick, secure, and real-time deployment of AI through Johnson & Johnson MedTech's digital surgery ecosystem.
|
|
2.
|
Stryker
|
Stryker Corporation is a leading medical technology company that offers a wide range of products and services in the healthcare industry, including the trauma fixation market. Stryker's trauma fixation division focuses on developing and manufacturing innovative solutions for the treatment of traumatic injuries. Stryker's trauma fixation portfolio includes a variety of internal and external fixation devices designed to stabilize and support fractured bones. These products are known for their quality, reliability, and advanced features, making them a preferred choice among healthcare professionals worldwide. Stryker is also known for its commitment to research and development, continually innovating to improve patient outcomes and enhance the efficiency of trauma fixation procedures. The company invests heavily in clinical research and collaborates with healthcare professionals to develop new and improved products.
|
|
North America, Middle East and Africa, Europe, South America, Asia-Pacific
|
In February 2022, Stryker completed the acquisition of Vocera Communications. This acquisition provides significant opportunities to advance innovations and accelerate our digital aspirations. Vocera brings a highly complementary and innovative portfolio to Stryker’s Medical division that will enhance the company’s Advanced Digital Healthcare offerings and further advance Stryker’s focus on preventing adverse events throughout the continuum of care.
|
|
3.
|
Zimmer Biomet
|
Zimmer Biomet is a global leader in musculoskeletal healthcare, including the trauma fixation market. The company is dedicated to helping people live fuller and more active lives by providing a comprehensive range of innovative solutions for orthopedic and trauma care. Zimmer Biomet offers a wide range of products and solutions designed to treat traumatic injuries and fractures. These include internal fixation devices such as plates, screws, and nails, and external fixation devices such as fixators and splints. Zimmer Biomet's trauma fixation products are known for their high quality, reliability, and advanced features, making them a preferred choice among healthcare professionals worldwide. Zimmer Biomet is committed to research and development, investing heavily in new technologies and innovative products to improve patient outcomes and enhance the efficiency of trauma fixation procedures. The company also provides comprehensive education and training programs to healthcare professionals to ensure the safe and effective use of its products.
|
|
North America, Middle East and Africa, Europe, South America, Asia-Pacific
|
In February 2021, Zimmer Biomet announced that the company has participated in a conference at Citi’s 2021 Healthcare Services, Medtech, Tools, and HCIT virtual conference. This conference results in expanding global recognition and thereby increased revenue for the market.
|
|
4.
|
Smith+Nephew
|
Smith+Nephew is a global medical technology company that specializes in orthopedic reconstruction, sports medicine, and trauma fixation. The company is known for its innovative products and solutions that help healthcare professionals treat patients with musculoskeletal conditions and injuries. The company offers a comprehensive range of products, including internal fixation devices such as plates, screws, and nails, and external fixation devices such as fixators and splints. These products are designed to stabilize and support fractured bones, helping patients recover and regain mobility. Smith+Nephew is committed to research and development, investing in new technologies and innovative solutions to improve patient outcomes and enhance the efficiency of trauma fixation procedures. The company also provides education and training programs to healthcare professionals to ensure the safe and effective use of its products.
|
|
North America, Middle East and Africa, Europe, South America, Asia-Pacific
|
In January 2021, Smith & Nephew announced that the company had acquired the Extremity Orthopaedics business of the Integra LifeSciences Holdings Corporation, a global medical device manufacturing company. This results in expanding the product portfolio of the company in the market.
|
|
5.
|
BIORETEC LTD
|
Bioretec Ltd. is a Finnish medical technology company that specializes in bioresorbable implants for orthopedic and trauma surgery. The company's mission is to develop innovative solutions that improve patient outcomes and reduce the need for additional surgeries.
Bioretec's flagship product is the Bioresorbable Fixation System (BRS), which is used to fix fractures and osteotomies in orthopedic and trauma surgery. The BRS is made from a unique bioresorbable polymer that gradually degrades in the body, eliminating the need for implant removal surgery. Bioretec is known for its commitment to research and development, working closely with healthcare professionals and research institutions to develop new and improved bioresorbable implants. The company also offers education and training programs to healthcare professionals to ensure the safe and effective use of its products.
|
|
North America, Middle East and Africa, Europe, South America, Asia-Pacific
|
In January 2022, Bioretec entered into a supply agreement with Meotec for magnesium alloy raw materials for bioresorbable RemeOs products. This agreement will put the company one step closer to commercializing its first RemeOs product in Europe and the U.S.
|
Conclusion
The market is a dynamic and competitive industry characterized by the presence of several key players, including Johnson & Johnson, Stryker, Zimmer Biomet, Smith & Nephew, and Bioretec Ltd. These companies offer a wide range of products and solutions for the treatment of traumatic injuries, including internal and external fixation devices. The market is driven by factors such as the rising incidence of traumatic injuries, the increasing geriatric population, and advancements in trauma fixation devices. Technological innovations, such as bioresorbable implants and minimally invasive surgery techniques, are also contributing to market growth. Overall, the future of the trauma fixation market looks promising, with an increasing focus on improving patient outcomes and reducing the need for additional surgeries through the development of advanced and bioresorbable implants.
